-
-
-
-
-
-
-
Form SC 13G/A Biotech Acquisition Co Filed by: Radcliffe Capital Management, L.P.
-
-
-
-
-
-
-
Form 25-NSE Biotech Acquisition Co Filed by: Nasdaq Stock Market LLC
-
-
-
-
-
-
-
Form 8-K Biotech Acquisition Co For: Jan 09
-
-
-
-
-
-
-
Form NT 10-Q Biotech Acquisition Co For: Sep 30
-
-
-
-
-
-
-
Biotech Acquisition Company Announces Submission of Prospectus Supplement to the Proxy Statement/Prospectus to The Registration Statement on Form S-4 Related to Proposed Merger with Blade Therapeutics
-
-
-
-
-
-
-
Biotech Acquisition (BIOT) Files Amended S4 for Proposed Merger with Blade Therapeutics
-
-
-
-
-
-
-
Blade Therapeutics Announces Successful Completion of Phase 1 Clinical Study that Evaluated Co-Administration of Cudetaxestat with Either of Two Approved Therapies for Idiopathic Pulmonary Fibrosis
-
1,173,576 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

